title: Cutaneous findings leading to a diagnosis of superior vena cava syndrome: A case report and review of the literature.
abstract: Superior vena cava syndrome, which occurs in approximately 15,000 persons in the United States annually, consists of a collection of symptoms and signs resulting from the obstruction of the superior vena cava (SVC). An early and prominent symptom of this condition is a constellation of superficial, dilated, vertically oriented and tortuous cutaneous venules or veins above the ribcage margins, often presenting as a blanchable violaceous eruption. Herein, we report a case of superior vena cava syndrome diagnosed in our dermatology clinic.
authors.affiliation: University of California at Davis, Department of Dermatology, Sacramento, California, USA.
authors.forename: Mondhipa
authors.initials: M
authors.lastname: Ratnarathorn
authors.forename: Errol
authors.initials: E
authors.lastname: Craig
mesh_terms: D000368:Aged; D018288:Carcinoma, Small Cell / Q000150:complications* / Q000000981:diagnostic imaging; D003907:Dexamethasone / Q000031:analogs & derivatives / Q000627:therapeutic use; D004417:Dyspnea / Q000209:etiology; D005076:Exanthema / Q000175:diagnosis; D017809:Fatal Outcome; D005938:Glucocorticoids / Q000627:therapeutic use; D006469:Hemoptysis / Q000209:etiology; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000000981:diagnostic imaging; D008297:Male; D010100:Oxygen / Q000627:therapeutic use; D011859:Radiography; D013479:Superior Vena Cava Syndrome / Q000175:diagnosis* / Q000209:etiology* / Q000628:therapy
chemical_list: D005938:Glucocorticoids; C004180:dexamethasone 21-phosphate; D003907:Dexamethasone; D010100:Oxygen